This drawback would interfere with the development of AHL-lactonase as peptide drugs. Since AHL-acylases have none of the drawbacks described above, Aac could become a potential quorum-quenching agent in the near feature. Conclusion This paper describes the identification of AHL-acylase, Aac, from R. solanacearumGMI1000 with ESI-MS mass spectrometry analysis and whole cell bioassay, together

with the analysis of MIC test of aculeacin A. The results showed strong evidence that the Aac in R. solanacearumGMI1000 functions as an AHL-acylase and not an aculeacin A acylase. Thus, we consider that renaming the aac gene of R. solanacearumGMI1000 as “”the alaS gene”" is necessary in further studies for the purpose of clarity. Moreover, this is the first report to find an AHL-acylase in a phytopathogen. Acknowledgements We would like to thank Dr. Christian Boucher (INRA-CNRS, France) for kindly Selleck Tideglusib providing us E. coli CA027ZC09, Dr. Paul Williams (University of Nottingham, UK) for kindly rendering us C. violaceum CV026, and the reviewers useful suggestions. This work was supported by the Frontier and Innovative Research of National Taiwan University under project number 96R0105. References 1. Swift S, Downie JA, Whitehead NA, Barnard AM, Salmond GP, Williams P: Quorum sensing as a population-density-dependent

determinant of bacterial physiology. Adv Microb Physiol 2001, 45:199–270.CrossRefBTK inhibitor PubMed 2. Winzer K, Williams P: Quorum sensing and ARRY-438162 order the regulation

of virulence gene expression in pathogenic bacteria. Int J Med Microbiol 2001, 291:131–143.CrossRefPubMed 3. Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP: Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev 2001, 25:365–404.CrossRefPubMed 4. Camara M, Williams P, Hardman A: Controlling infection by tuning in and turning down the Cediranib (AZD2171) volume of bacterial small-talk. Lancet Infect Dis 2002, 2:667–676.CrossRefPubMed 5. de Kievit TR, Iglewski BH: Bacterial quorum sensing in pathogenic relationships. Infect Immun 2000, 68:4839–4849.CrossRefPubMed 6. Finch RG, Pritchard DI, Bycroft BW, Williams P, Stewart GS: Quorum sensing: a novel target for anti-infective therapy. J Antimicrob Chemother 1998, 42:569–571.CrossRefPubMed 7. Hentzer M, Givskov M: Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J Clin Invest 2003, 112:1300–1307.PubMed 8. Rasmussen TB, Givskov M: Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol 2006, 296:149–161.CrossRefPubMed 9. Dong YH, Zhang LH: Quorum sensing and quorum-quenching enzymes. J Microbiol 2005, 43:101–109.PubMed 10. Hoang TT, Schweizer HP: Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol 1999, 181:5489–5497.PubMed 11.